HOUSTON – (Jan. 22, 2013) – Baylor College of Medicine is the lead site
on a study launched by the National Institute of Allergy and Infectious
Diseases, part of the National Institutes of Health, that will measure
the safety and the antibody responses among healthy adults immunized
with an H3N2v vaccine, also known as H3N2 variant.
Online Subscription required: http://www.thecherokeean.com/news/2013-01-23/Health/
No comments:
Post a Comment